Martini, S., Figini, M., Croce, A., Frigerio, B., Pennati, M., Gianni, A. M., . . . Satta, A. (2020). Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody. Cells.
Chicago-стиль цитированияMartini, Silvia, et al. "Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody." Cells 2020.
MLA-цитированиеMartini, Silvia, et al. "Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody." Cells 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.